16/03/2026
With our ongoing CUV105 clinical trial, CLINUVEL is investigating a new, systemic repigmentation treatment for people living with vitiligo.
We are excited to announce that Dr Hannah Wanyika, a renowned dermatology expert working on the trial, will join us in Denver for , sharing key insights from CUV105.
Visit the Pavilion of Photomedicine during AAD to hear from Dr Wanyika and more guest speakers on topics such as vitiligo, psychodermatology and our melanocortin technology.
Follow our channels for the latest updates!